BC-CfE Updates

Treatment as Prevention: Adapting TasP-HIV to syndemics

Presenter:
Dr. Julio Montaner
Executive Director & Physician-in-Chief
BC Centre for Excellence in HIV/AIDS

Modelling update

Presenter:
Dr. Viviane Dias Lima
Senior Scientist & Head of Modelling and Forecasting
BC Centre for Excellence in HIV/AIDS

Doxycycline for the prevention of bacterial STIs: Impacts on antimicrobial resistance

Presenter:
Dr. Victor Leung
Clinical Professor
The University of British Columbia

Epidemiology of HCV

Presenter:
Dr. Naveed Janjua
Executive Director, Data and Analytic Services
BC Centre for Disease Control

Phylogenetic insights in HCV transmission

Presenter:
Dr. Jeffrey Joy
Senior Research Scientist
BC Centre for Excellence in HIV/AIDS

HCV: Practical aspects: Decreasing barriers to care from initiation to re-treatment

Presenter:
Dr. Alnoor Ramji
Clinical Associate, Professor of Medicine
The University of British Columbia

Delivering comprehensive primary care for the complex populations in Vancouver’s Downtown Eastside

Presenter:
Dr. Silvia Guillemi
Clinical Professor, Department of Family Practice
The University of British Columbia

Delivering comprehensive services for the complex populations in Vancouver’s Downtown Eastside

Presenter:
Yogeeta Dosanjh
Director, Clinical Operations
BC Centre for Excellence in HIV/AIDS

Addressing syndemics at Hope to Health: Research & evaluation update

Presenter:
Dr. Kate Salters
Senior Research Scientist
BC Centre for Excellence in HIV/AIDS

Symptom-inhibited fentanyl induction (SIFI)

Presenter:
Dr. Anil Maharaj
Assistant Professor, Faculty of Pharmaceutical Sciences
The University of British Columbia

Buprenorphine transdermal to buprenorphine extended release study

Presenter:
Chase Fisher
Clinical Pharmacist
Hope to Health Research & Innovation Centre

Ritonavir boosting: Rethinking old tools for new public health challenges

Presenter:
Dr. Anil Maharaj
Assistant Professor, Faculty of Pharmaceutical Sciences
The University of British Columbia

Welcome Remarks

Speakers:
Fiona Dalton and Eric Harris

HIV in the World: Are we Winning or Losing?

Speaker:
Dr. Brian Williams

USA Perspective

Speaker:
Dr. Jonathan Mermin

PEPfAR Perspective

Speakers:
Dr. Rebecca Bunnell/Dr. Emily Kainne Dokubo

Navigating the Last Mile: Innovative Solutions for Ending the Global HIV Pandemic

Speaker:
Dr. Reuben Granich

Round Table: Where do we go from here?

Speakers:
Dr. Brian Williams/Dr. Jonathan Mermin/Dr. Rebecca Bunnell/Dr. Emily Kainne / Dr. Dokubo/Dr. Reuben Granich/Dr. Julio Montaner

The Evolving Mandate of the BC-CfE

Speaker:
Dr. Julio Montaner

H2H: Quality Outcomes in Inner City Primary Care

Speakers:
David Hall & Rolando Barrios

H2H: Addictions

Speaker:
Martha Ignaszewski

H2H: Supervised Consumption

Speakers:
Zoran Barazanci & Christina Fulton

Doxycycline Program

Speaker:
Junine Toy

Sexually Transmitted Infections Update

Speaker:
Victor Leung

Syphilis Update

Speaker:
Peter Phillips

BC Minister of Mental Health & Addictions Hon. Jennifer Whiteside addresses the Spring 2024 BC-CfE Update

Speaker:
Hon. Jennifer Whiteside
All Videos
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search